<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04503005</url>
  </required_header>
  <id_info>
    <org_study_id>FaTE-TRE</org_study_id>
    <nct_id>NCT04503005</nct_id>
  </id_info>
  <brief_title>Fasting Time Effects in Time-Restricted Eating (FaTE-TRE)</brief_title>
  <acronym>FaTE-TRE</acronym>
  <official_title>Effect of Fasting Duration During a Time-Restricted Eating Diet Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the past century, lifestyles and eating habits have rapidly changed, helping to increase&#xD;
      the onset of conditions such as obesity, metabolic syndrome and the risk of cardiovascular&#xD;
      and metabolic diseases such as diabetes.&#xD;
&#xD;
      Recently, dietary regimens such as calorie restriction and intermittent fasting have been&#xD;
      promoted as new strategies for reducing obesity and related co-morbidities. These strategies&#xD;
      have proven effective in reducing body fat, improving blood pressure, lipid profile and&#xD;
      insulin resistance in overweight individuals. However, due to the rigidity of these food&#xD;
      protocols, the adherence of subjects to the diet is often limited or maintained only for&#xD;
      short periods.&#xD;
&#xD;
      Time-Restricted Eating (TRE) is a less extreme form of intermittent fasting, in which the&#xD;
      subject's daily calorie intake is consumed only in a certain period of time during the day&#xD;
      (normally 8-12 hours). TRE have been able to reduce fat mass, pro-inflammatory markers (eg&#xD;
      IL-6, TNF-a) and have improved some biomarkers related to cardiovascular risks (eg Insulin,&#xD;
      HDL, TG).&#xD;
&#xD;
      The literature offers numerous versions of intermittent fasting, and the role of fasting&#xD;
      duration is not yet fully clear. Thus. the aim of the present study is to investigate the&#xD;
      effect od different duration of fasting in a TRE protocol on body composition and lipid and&#xD;
      inflammatory profile. Moreover, the study intended to explore the effect of 2 month of TRE on&#xD;
      long term maintenance of diet habits, body composition, lipid and inflammatory profile.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>2 months</time_frame>
    <description>change of body fat percentage measured via DEXA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood cholesterol (total, HDL, LDL)</measure>
    <time_frame>2 months</time_frame>
    <description>Change in blood lipid profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood cytokines (IL-6; IL-1, TNF-a)</measure>
    <time_frame>2 months</time_frame>
    <description>Change in blood inflammatory markers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morningness-Eveningness Questionnaire (MEQ) on chronotype</measure>
    <time_frame>6 month</time_frame>
    <description>effect od diet in eating behaviours. Minimum value is 16, maximum value is 86 Morningness-Eveningness Questionnaire (MEQ) scale is 0-41, evening type; 42-58 Neither-type; 58-68 Morning-type</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy Diet</condition>
  <condition>Fasting, Intermittent</condition>
  <arm_group>
    <arm_group_label>Effect of fasting duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>study the effect of different daily fasting duration on body composition and blood lipid and inflammatory markers in healthy adults.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Effect of time restricted eating protocol on chronotype</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>study the effect of 2 month of time restricted eating on the chronotype profile of healthy adults.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Time Restricted Eating</intervention_name>
    <description>Effect of 16, 14 or 12 hours of daily fasting</description>
    <arm_group_label>Effect of fasting duration</arm_group_label>
    <arm_group_label>Effect of time restricted eating protocol on chronotype</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI between 18-30 kg/m2&#xD;
&#xD;
          -  Stable body weight for at least 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  type 2 Diabetes or pre-diabetes for ADA guidelines&#xD;
&#xD;
          -  Significant Chronic disease&#xD;
&#xD;
          -  recent and acute inflammatory status&#xD;
&#xD;
          -  Recent (within 3 months) treatment with anabolic steroids, systemic corticosteroids or&#xD;
             estrogen.&#xD;
&#xD;
          -  regular exercise training (≥ 2 sessions/week) or ≥ 10,000 steps/day&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tatiana Moro, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Padova</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tatiana Moro, Ph.D</last_name>
    <phone>0498275306</phone>
    <email>tatiana.moro@unipd.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nutrition and Exercise Lab, DSB, University of Padova</name>
      <address>
        <city>Padova</city>
        <zip>35131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatiana Moro, PhD</last_name>
      <phone>0498275306</phone>
      <email>tatiana.moro@unipd.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 30, 2020</study_first_submitted>
  <study_first_submitted_qc>August 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2020</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Padova</investigator_affiliation>
    <investigator_full_name>Antonio Paoli</investigator_full_name>
    <investigator_title>Full Professor</investigator_title>
  </responsible_party>
  <keyword>time restricted eating</keyword>
  <keyword>intermitted fasting</keyword>
  <keyword>body composition</keyword>
  <keyword>metabolism</keyword>
  <keyword>inflammation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to make IPD available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

